Sarepta Therapeutics Inc (SRPT)
110.50
-0.36
(-0.32%)
USD |
NASDAQ |
Nov 21, 16:00
112.00
+1.50
(+1.36%)
After-Hours: 06:51
Sarepta Therapeutics Profit Margin (Quarterly): 7.19% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 7.19% |
| June 30, 2024 | 1.78% |
| March 31, 2024 | 8.74% |
| December 31, 2023 | 11.51% |
| September 30, 2023 | -12.34% |
| June 30, 2023 | -9.16% |
| March 31, 2023 | -203.8% |
| December 31, 2022 | -42.27% |
| September 30, 2022 | -111.9% |
| June 30, 2022 | -99.14% |
| March 31, 2022 | -49.82% |
| December 31, 2021 | -60.55% |
| September 30, 2021 | -25.42% |
| June 30, 2021 | -49.61% |
| March 31, 2021 | -113.8% |
| December 31, 2020 | -130.4% |
| September 30, 2020 | -136.5% |
| June 30, 2020 | -109.8% |
| March 31, 2020 | -15.39% |
| December 31, 2019 | -235.4% |
| September 30, 2019 | -127.5% |
| June 30, 2019 | -292.0% |
| March 31, 2019 | -88.08% |
| December 31, 2018 | -166.9% |
| September 30, 2018 | -97.33% |
| Date | Value |
|---|---|
| June 30, 2018 | -148.6% |
| March 31, 2018 | -54.74% |
| December 31, 2017 | -41.90% |
| September 30, 2017 | -103.9% |
| June 30, 2017 | -180.1% |
| March 31, 2017 | |
| December 31, 2016 | -1.63K% |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -5.16K% |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | -164.5K% |
| September 30, 2014 | -2.76K% |
| June 30, 2014 | -1.31K% |
| March 31, 2014 | -464.4% |
| December 31, 2013 | -335.9% |
| September 30, 2013 | -1.01K% |
| June 30, 2013 | -645.6% |
| March 31, 2013 | -940.6% |
| December 31, 2012 | -846.1% |
| September 30, 2012 | -654.3% |
| June 30, 2012 | 71.72% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-235.4%
Minimum
Dec 2019
11.51%
Maximum
Dec 2023
-68.81%
Average
-49.71%
Median
Profit Margin (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 34.10% |
| Madrigal Pharmaceuticals Inc | -172.0% |
| Vertex Pharmaceuticals Inc | 37.71% |
| Viking Therapeutics Inc | -- |
| Regenxbio Inc | -246.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 12.48% |
| Return on Assets | 3.66% |
| Return on Invested Capital | 5.51% |
| Gross Profit Margin (Quarterly) | 80.37% |
| Operating Margin (Quarterly) | 4.75% |
| Return on Net Operating Assets | 8.26% |